Indian Journal of Urology Users online:1501  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents
Salehi, Fokou, Yamthe, Tali, Adetunji, Rahavian, Mudau, Martorell, Setzer, Rodrigues, Martins, Cho, Sharifi-Rad
Nutrients.2019;11(7)1483
[DOI]
2Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers
Alexandru Mihai Nicolae,Niranjan Venugopal,Ananth Ravi
Cancer Nanotechnology.2016;7(1)1483
[DOI]
3MRI-guided focal therapy of prostate cancer
Melvy Sarah Mathew,Aytekin Oto
Future Oncology.2017;13(6)537
[DOI]
4A systematic review on multiparametric MR imaging in prostate cancer detection
Roberta Fusco,Mario Sansone,Vincenza Granata,Sergio Venanzio Setola,Antonella Petrillo
Infectious Agents and Cancer.2017;12(1)537
[DOI]
5Detección precoz de cáncer de próstata: Controversias y recomendaciones actuales
Ramos Christian,Fullá O. Juan,Mercado C. Alejandro
Revista Médica Clínica Las Condes.2018;29(2)128
[DOI]
6A novel approach for assessment of prostate cancer aggressiveness using survivin-driven tumour-activatable minicircles
TianDuo Wang,Yuanxin Chen,John. A. Ronald
Gene Therapy.2019;26(5)177
[DOI]
7A novel approach for assessment of prostate cancer aggressiveness using survivin-driven tumour-activatable minicircles
Violeta Catalá,Jonathan Hernández,Ferran Algaba,Oscar Laucirica,Joan C. Vilanova
Gene Therapy.2018;26(5)77
[DOI]
8Evaluating the Role of mpMRI in Prostate Cancer Assessment
Francesca V. Mertan,Rose Berman,Kathryn Szajek,Peter A. Pinto,Peter L. Choyke,Baris Turkbey
Expert Review of Medical Devices.2016;13(2)129
[DOI]
9The value of MR textural analysis in prostate cancer
N. Patel,A. Henry,A. Scarsbrook
Clinical Radiology.2019;74(11)876
[DOI]
10Photoacoustic imaging of clofazimine hydrochloride nanoparticle accumulation in cancerous vs normal prostates
Joel W. Y. Tan,Mikhail D. Murashov,Gus R. Rosania,Xueding Wang,Juri G. Gelovani
PLOS ONE.2019;14(7)e0219655
[DOI]
11Incorporating imaging into personalized medicine for the detection of prostate cancer
Francesca Mertan,Baris Turkbey
Pharmacological Research.2016;114(7)163
[DOI]
12Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study
Matthew D. Greer,Anna M. Brown,Joanna H. Shih,Ronald M. Summers,Jamie Marko,Yan Mee Law,Sandeep Sankineni,Arvin K. George,Maria J. Merino,Peter A. Pinto,Peter L. Choyke,Baris Turkbey
Journal of Magnetic Resonance Imaging.2017;45(2)579
[DOI]
13Radiomics for peripheral zone and intra-prostatic urethra segmentation in MR imaging
Praful Hambarde,Sanjay N. Talbar,Nilesh Sable,Abhishek Mahajan,Satishkumar S. Chavan,Meenakshi Thakur
Biomedical Signal Processing and Control.2019;51(2)19
[DOI]
14Anatomic and Molecular Imaging in Prostate Cancer
Eric T. Miller,Amirali Salmasi,Robert E. Reiter
Cold Spring Harbor Perspectives in Medicine.2018;8(3)a030619
[DOI]
15Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2
Zan Ke,Liang Wang,Xiang-De Min,Zhao-Yan Feng,Zhen Kang,Pei-Pei Zhang,Ba-Sen Li,Hui-Juan You,Sheng-Chao Hou
Chinese Medical Journal.2018;131(14)1666
[DOI]
16Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre
Francesca Kum,Adam Jones,Raj Nigam
World Journal of Urology.2019;37(2)337
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us

HEALTHWARE INDIA